blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2488022

EP2488022 - COMPOSITIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.11.2018
Database last updated on 13.07.2024
FormerThe patent has been granted
Status updated on  08.12.2017
FormerGrant of patent is intended
Status updated on  04.07.2017
FormerExamination is in progress
Status updated on  04.11.2016
Most recent event   Tooltip26.06.2020Lapse of the patent in a contracting state
New state(s): MK		published on 29.07.2020  [2020/31]
Applicant(s)For all designated states
Mochida Pharmaceutical Co., Ltd.
7 Yotsuya 1-chome Shinjuku-ku
Tokyo 160-8515 / JP
[2017/43]
Former [2017/40]For all designated states
GlaxoSmithKline LLC
251 Little Falls Drive
Wilmington, DE 19808 / US
Former [2016/20]For all designated states
GlaxoSmithKline LLC
Corporation Service Company
2711 Centerville Road
Suite 400
Wilmington DE 19808 / US
Former [2014/15]For all designated states
GlaxoSmithKline LLC
Corporation Service Company
2711 Centreville Road
Suite 400
Wilmington, Delaware 19808 / US
Former [2012/34]For all designated states
GlaxoSmithKline LLC
One Franklin Plaza 200 North 16th Street
Philadelphia, PA 19102 / US
Inventor(s)01 / ABU-BAKER, Omar, Abdelfattah
1250 South Collegeville Road
Collegeville, PA 19426 / US
02 / MACKENZIE, Donald, Colin
709 Swedeland Road
King of Prussia, PA 19406 / US
03 / PAN, Rennan
1250 South Collegeville Road
Collegeville, PA 19426 / US
 [2012/34]
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
[2018/02]
Former [2012/34]Fowler, Gavin James, et al
GlaxoSmithKline
Global Patents CN925.1
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
Application number, filing date10824162.115.10.2010
[2018/02]
WO2010US52840
Priority number, dateUS20090267697P08.12.2009         Original published format: US 267697 P
US20090252310P16.10.2009         Original published format: US 252310 P
[2012/34]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011047259
Date:21.04.2011
Language:EN
[2011/16]
Type: A1 Application with search report 
No.:EP2488022
Date:22.08.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 21.04.2011 takes the place of the publication of the European patent application.
[2012/34]
Type: B1 Patent specification 
No.:EP2488022
Date:10.01.2018
Language:EN
[2018/02]
Search report(s)International search report - published on:US21.04.2011
(Supplementary) European search report - dispatched on:EP22.01.2014
ClassificationIPC:A61K9/08, A61K47/34, A61K47/14, A61K9/107, A23D7/015, A23L33/12
[2016/46]
CPC:
A61K31/202 (EP,US); A23D7/011 (EP,US); A23D7/015 (EP,US);
A23L33/12 (EP,US); A61K31/20 (EP,US); A61K31/225 (EP,US);
A61K45/06 (EP,US); A61K47/14 (US); A61K47/34 (EP,US);
A61K47/44 (US); A61K9/08 (EP,US); A61K9/107 (US);
A61K9/1075 (EP,US); A61K9/14 (US); A61P3/02 (EP);
A61P3/06 (EP,US); A61P43/00 (EP); A61P9/00 (EP,US);
A61P9/10 (EP); A23V2002/00 (EP,US) (-)
C-Set:
A61K31/20, A61K2300/00 (EP,US);
A61K31/225, A61K2300/00 (US,EP);
A23V2002/00, A23V2200/254, A23V2200/326, A23V2250/1868, A23V2250/187 (US,EP)
Former IPC [2012/34]A01N37/02, A61K31/225, A61K31/20
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2012/34]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:ZUSAMMENSETZUNGEN[2012/34]
English:COMPOSITIONS[2012/34]
French:COMPOSITIONS[2012/34]
Entry into regional phase09.05.2012National basic fee paid 
09.05.2012Search fee paid 
09.05.2012Designation fee(s) paid 
09.05.2012Examination fee paid 
Examination procedure09.05.2012Examination requested  [2012/34]
06.08.2014Amendment by applicant (claims and/or description)
15.10.2015Observations by third parties
27.01.2016Despatch of a communication from the examining division (Time limit: M06)
21.07.2016Reply to a communication from the examining division
28.10.2016Despatch of a communication from the examining division (Time limit: M06)
28.04.2017Reply to a communication from the examining division
03.07.2017Communication of intention to grant the patent
08.11.2017Fee for grant paid
08.11.2017Fee for publishing/printing paid
08.11.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  27.01.2016
Opposition(s)11.10.2018No opposition filed within time limit [2018/51]
Fees paidRenewal fee
05.10.2012Renewal fee patent year 03
07.10.2013Renewal fee patent year 04
07.10.2014Renewal fee patent year 05
07.10.2015Renewal fee patent year 06
07.10.2016Renewal fee patent year 07
10.10.2017Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU15.10.2010
AL10.01.2018
AT10.01.2018
CY10.01.2018
CZ10.01.2018
DK10.01.2018
EE10.01.2018
FI10.01.2018
HR10.01.2018
LT10.01.2018
LV10.01.2018
MC10.01.2018
MK10.01.2018
NL10.01.2018
PL10.01.2018
PT10.01.2018
RO10.01.2018
RS10.01.2018
SE10.01.2018
SI10.01.2018
SK10.01.2018
SM10.01.2018
TR10.01.2018
BG10.04.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
[2020/31]
Former [2020/30]HU15.10.2010
AL10.01.2018
AT10.01.2018
CY10.01.2018
CZ10.01.2018
DK10.01.2018
EE10.01.2018
FI10.01.2018
HR10.01.2018
LT10.01.2018
LV10.01.2018
MC10.01.2018
NL10.01.2018
PL10.01.2018
PT10.01.2018
RO10.01.2018
RS10.01.2018
SE10.01.2018
SI10.01.2018
SK10.01.2018
SM10.01.2018
TR10.01.2018
BG10.04.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
Former [2020/27]AL10.01.2018
AT10.01.2018
CY10.01.2018
CZ10.01.2018
DK10.01.2018
EE10.01.2018
FI10.01.2018
HR10.01.2018
LT10.01.2018
LV10.01.2018
MC10.01.2018
NL10.01.2018
PL10.01.2018
PT10.01.2018
RO10.01.2018
RS10.01.2018
SE10.01.2018
SI10.01.2018
SK10.01.2018
SM10.01.2018
TR10.01.2018
BG10.04.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
Former [2020/16]AL10.01.2018
AT10.01.2018
CY10.01.2018
CZ10.01.2018
DK10.01.2018
EE10.01.2018
FI10.01.2018
HR10.01.2018
LT10.01.2018
LV10.01.2018
MC10.01.2018
NL10.01.2018
PL10.01.2018
RO10.01.2018
RS10.01.2018
SE10.01.2018
SI10.01.2018
SK10.01.2018
SM10.01.2018
TR10.01.2018
BG10.04.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
Former [2019/28]AL10.01.2018
AT10.01.2018
CY10.01.2018
CZ10.01.2018
DK10.01.2018
EE10.01.2018
FI10.01.2018
HR10.01.2018
LT10.01.2018
LV10.01.2018
MC10.01.2018
NL10.01.2018
PL10.01.2018
RO10.01.2018
RS10.01.2018
SE10.01.2018
SI10.01.2018
SK10.01.2018
SM10.01.2018
BG10.04.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
Former [2019/13]AL10.01.2018
AT10.01.2018
CY10.01.2018
CZ10.01.2018
DK10.01.2018
EE10.01.2018
FI10.01.2018
HR10.01.2018
LT10.01.2018
LV10.01.2018
NL10.01.2018
PL10.01.2018
RO10.01.2018
RS10.01.2018
SE10.01.2018
SI10.01.2018
SK10.01.2018
SM10.01.2018
BG10.04.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
Former [2018/52]AL10.01.2018
AT10.01.2018
CY10.01.2018
CZ10.01.2018
DK10.01.2018
EE10.01.2018
FI10.01.2018
HR10.01.2018
LT10.01.2018
LV10.01.2018
NL10.01.2018
PL10.01.2018
RO10.01.2018
RS10.01.2018
SE10.01.2018
SK10.01.2018
SM10.01.2018
BG10.04.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
Former [2018/51]AL10.01.2018
AT10.01.2018
CY10.01.2018
CZ10.01.2018
DK10.01.2018
EE10.01.2018
FI10.01.2018
HR10.01.2018
LT10.01.2018
LV10.01.2018
NL10.01.2018
PL10.01.2018
RO10.01.2018
RS10.01.2018
SE10.01.2018
SK10.01.2018
BG10.04.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
Former [2018/50]AL10.01.2018
AT10.01.2018
CY10.01.2018
CZ10.01.2018
EE10.01.2018
FI10.01.2018
HR10.01.2018
LT10.01.2018
LV10.01.2018
NL10.01.2018
PL10.01.2018
RO10.01.2018
RS10.01.2018
SE10.01.2018
SK10.01.2018
BG10.04.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
Former [2018/49]AL10.01.2018
AT10.01.2018
CY10.01.2018
EE10.01.2018
FI10.01.2018
HR10.01.2018
LT10.01.2018
LV10.01.2018
NL10.01.2018
PL10.01.2018
RO10.01.2018
RS10.01.2018
SE10.01.2018
BG10.04.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
Former [2018/46]AL10.01.2018
AT10.01.2018
CY10.01.2018
FI10.01.2018
HR10.01.2018
LT10.01.2018
LV10.01.2018
NL10.01.2018
PL10.01.2018
RS10.01.2018
SE10.01.2018
BG10.04.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
Former [2018/40]AT10.01.2018
CY10.01.2018
FI10.01.2018
HR10.01.2018
LT10.01.2018
LV10.01.2018
NL10.01.2018
PL10.01.2018
RS10.01.2018
SE10.01.2018
BG10.04.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
Former [2018/39]AT10.01.2018
CY10.01.2018
FI10.01.2018
HR10.01.2018
LT10.01.2018
LV10.01.2018
NL10.01.2018
PL10.01.2018
RS10.01.2018
SE10.01.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
Former [2018/37]CY10.01.2018
FI10.01.2018
HR10.01.2018
LT10.01.2018
NL10.01.2018
PL10.01.2018
NO10.04.2018
GR11.04.2018
Former [2018/36]CY10.01.2018
FI10.01.2018
HR10.01.2018
LT10.01.2018
NL10.01.2018
PL10.01.2018
NO10.04.2018
Former [2018/35]CY10.01.2018
FI10.01.2018
HR10.01.2018
LT10.01.2018
NL10.01.2018
NO10.04.2018
Former [2018/34]FI10.01.2018
LT10.01.2018
NL10.01.2018
NO10.04.2018
Documents cited:Search[X]US6284268  (MISHRA AWADHESH [CA], et al) [X] 1,4-6,9-12,14,15 * table 2 last example, Example 11: Formulation 2, Formulation 13;; claims 1-9 *;
 [XA]WO0217906  (PILOT THERAPEUTICS INC [US], et al) [X] 1,4-6,9-12,14,15 * example 1; claim - * [A] 2,3;
 [X]WO2006096806  (RELIANT PHARMACEUTIACALS INC [US], et al) [X] 6-9,11-15 * Formulations 5,15,16,20;; claim - *;
 [X]US2006251685  (YU ZHI-JIAN [US], et al) [X] 1,4-6,9-12,14 * example -; claims 1, 9-16 *;
 [XA]US2007031538  (KONUKLAR GUL [US], et al) [X] 1,4,6,9,12,14,15 * Table examples 5 and 15;; claim - * [A] 2,3;
 [X]WO2008101344  (TOMLINSON PETER [CA]) [X] 1,4-6,9-12,14,15 * example 1 5; claims 45-52 *;
 [XA]WO2009117152  (VIRUN INC [US], et al) [X] 1,4-6,9-12,14,15 * Example 2A(xi) p.174, Example 2C(iii) p.185,;; claim - *[A] 2,3
International search[X]US6284268  (MISHRA AWADHESH [CA], et al);
 [X]US2006251685  (YU ZHI-JIAN [US], et al);
 [A]US2009012167  (RONGEN ROELOF M L [US], et al)
otherEP1906980
 EP2008661
    - "AKHAROTAGUNAAH", TKDL, Database accession no. RS/5029, XP003030914
    - BRHAT NIGHANTU RATNAKARA, Saligramanighantubhusanam, (19970000), vol. 4, page 456
    - "Erandatailaguna", TKDL, Database accession no. BP/1755, XP055248504
    - AGNIVESA, CARAKA SAMHITA. 6th ed., (20000000), vol. I, page 219
    - "Gul-e- kataan", TKDL, Database accession no. FA1/65PP, XP055248505
    - MOHAMMAD AZAM KHAN, Muheet-e-Azam, (18990000), vol. IV, page 35
    - "Erandatailagunaah", TKDL, Database accession no. RS/4470, XP055248506
    - BRHAT NIGHANTU RATNAKARA, Saligramanighantubhusanam, (19970000), vol. 4
    - "Eranda Taila Guna", TKDL, Database accession no. AK12/487A, XP055248508
    - MAHENDRA BHAUGIKA, Dhanvantarinighantauh, (20020000), page 200
    - "Aksoda (Bijadala)", TKDL, Database accession no. RG/3581, XP003030915
    - GOVT OF INDIA, The Ayurvedic Pharmacopoiea of India, (19990000), vol. II, pages 3 - 4
    - "Vijaya kalpah", TKDL, Database accession no. RS13/318Z11, XP03029061
    - MANTHANA BHAIRAVA, ANANDAKANDAH. 1st ed., (19520000), page 245
    - "Dawa Barae Waja-ul-qalb", TKDL, Database accession no. NA4/1332, XP003029059
    - MOHAMMAD NAJMUL GHANI KHAN, Qaraabaadeen Najm-al-Ghani, (19280000), page 215
    - "Sarpagandhaghana Vati", TKDL, Database accession no. RG12/869, XP055219259
    - AYURVEDA SARASARHGRAHAH, (20030000), page 467
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.